City Research Online

A DYNC1H1 mutation in autosomal dominant spinal muscular atrophy shows the potential of pharmacological inhibition of histone deacetylase 6 as a treatment for disease associated cellular phenotypes

Green, R., Simoes, F. A., Reyes-Aldasoro, C. C. , Rossor, A. M., Scoto, M., Barri, M., Greensmith, L., Muntoni, F., Reilly, M. M. & Hafezparast, M. (2016). A DYNC1H1 mutation in autosomal dominant spinal muscular atrophy shows the potential of pharmacological inhibition of histone deacetylase 6 as a treatment for disease associated cellular phenotypes. Journal Of The Peripheral Nervous System, 21(3), pp. 229-314. doi: 10.1111/jns.12181

Publication Type: Article
Additional Information: This is the peer reviewed version of the following article: Green, R., Simoes, F. A., Reyes-Aldasoro, C. C., Rossor, A. M., Scoto, M., Barri, M., Greensmith, L., Muntoni, F., Reilly, M. M. & Hafezparast, M. (2016). A DYNC1H1 mutation in autosomal dominant spinal muscular atrophy shows the potential of pharmacological inhibition of histone deacetylase 6 as a treatment for disease associated cellular phenotypes. Journal Of The Peripheral Nervous System, 21(3), pp. 261-262., which is published in final form at http://dx.doi.org/10.1111/jns.12181. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
Subjects: R Medicine > RC Internal medicine
T Technology > TK Electrical engineering. Electronics Nuclear engineering
Departments: School of Science & Technology > Engineering
School of Science & Technology > Computer Science > giCentre
SWORD Depositor:
[thumbnail of GreenR.pdf]
Preview
Text - Accepted Version
Download (56kB) | Preview

Export

Add to AnyAdd to TwitterAdd to FacebookAdd to LinkedinAdd to PinterestAdd to Email

Downloads

Downloads per month over past year

View more statistics

Actions (login required)

Admin Login Admin Login